Sunil Kumar Panda

Title: **Sunil Kumar Panda: Innovator in Pharmaceutical Formulations**

Introduction

Sunil Kumar Panda, based in Noida, India, is a distinguished inventor with a remarkable contribution to the pharmaceutical industry. He holds two patents that highlight his innovative approach to drug formulation, particularly in the realm of proton pump inhibitors.

Latest Patents

One of Sunil's latest patents includes a "Delayed release pharmaceutical composition of pantoprazole and process for formulation thereof." This invention discloses a stable delayed-release multiparticulate powder for oral suspension of proton pump inhibitor compounds. The formulation comprises a core with an effective amount of proton pump inhibitor combined with one or more pharmaceutical excipients. The invention also incorporates at least one water-soluble seal coating over the core and at least one enteric coating layer, ensuring the core is free of surfactants. The newly developed formulations have exhibited essential pharmaceutical attributes such as optimal drug release, stability, and reduced sticking to nasogastric and gastronomy tubes.

Additionally, another patent of his focuses on a similar delayed release pharmaceutical composition of pantoprazole, which further emphasizes the core’s composition, including disintegrants and/or surfactants. Both inventions address the limitations presented in prior art, which necessitated higher amounts of various excipients to achieve the required technical specifications.

Career Highlights

Sunil Kumar Panda is currently associated with Jubilant Generics Limited, where he continues to contribute to the advancement of pharmaceutical products. His work not only innovates drug delivery systems but also aims to enhance patient comfort and medication efficacy.

Collaborations

Throughout his career, Sunil has collaborated with several notable professionals, including Kamal Surendrakumar Mehta and Saurabh Srivastava. These collaborations have facilitated the sharing of ideas and expertise, further driving innovation in their projects.

Conclusion

Sunil Kumar Panda stands as a prominent figure in the field of pharmaceutical inventions. His patents reflect a commitment to improving drug formulations, showcasing his ability to tackle challenges with effective solutions. As he continues to work with Jubilant Generics Limited, the pharmaceutical community eagerly anticipates his future contributions.